• Je něco špatně v tomto záznamu ?

Management of pheochromocytomas and paragangliomas: Review of current diagnosis and treatment options

M. Eid, J. Foukal, D. Sochorová, Š. Tuček, K. Starý, Z. Kala, J. Mayer, R. Němeček, J. Trna, L. Kunovský

. 2023 ; 12 (13) : 13942-13957. [pub] 20230505

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, přehledy, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc23017004

Pheochromocytomas (PCCs) are rare neuroendocrine tumors derived from the chromaffin cells of the adrenal medulla. When these tumors have an extra-adrenal location, they are called paragangliomas (PGLs) and arise from sympathetic and parasympathetic ganglia, particularly of the para-aortic location. Up to 25% of PCCs/PGLs are associated with inherited genetic disorders. The majority of PCCs/PGLs exhibit indolent behavior. However, according to their affiliation to molecular clusters based on underlying genetic aberrations, their tumorigenesis, location, clinical symptomatology, and potential to metastasize are heterogenous. Thus, PCCs/PGLs are often associated with diagnostic difficulties. In recent years, extensive research revealed a broad genetic background and multiple signaling pathways leading to tumor development. Along with this, the diagnostic and therapeutic options were also expanded. In this review, we focus on the current knowledge and recent advancements in the diagnosis and treatment of PCCs/PGLs with respect to the underlying gene alterations while also discussing future perspectives in this field.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23017004
003      
CZ-PrNML
005      
20231026105358.0
007      
ta
008      
231013s2023 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/cam4.6010 $2 doi
035    __
$a (PubMed)37145019
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Eid, Michal $u Department of Hematology, Oncology and Internal Medicine, University Hospital Brno, Faculty of Medicine, Masaryk University, Brno, Czech Republic $1 https://orcid.org/0000000244335326
245    10
$a Management of pheochromocytomas and paragangliomas: Review of current diagnosis and treatment options / $c M. Eid, J. Foukal, D. Sochorová, Š. Tuček, K. Starý, Z. Kala, J. Mayer, R. Němeček, J. Trna, L. Kunovský
520    9_
$a Pheochromocytomas (PCCs) are rare neuroendocrine tumors derived from the chromaffin cells of the adrenal medulla. When these tumors have an extra-adrenal location, they are called paragangliomas (PGLs) and arise from sympathetic and parasympathetic ganglia, particularly of the para-aortic location. Up to 25% of PCCs/PGLs are associated with inherited genetic disorders. The majority of PCCs/PGLs exhibit indolent behavior. However, according to their affiliation to molecular clusters based on underlying genetic aberrations, their tumorigenesis, location, clinical symptomatology, and potential to metastasize are heterogenous. Thus, PCCs/PGLs are often associated with diagnostic difficulties. In recent years, extensive research revealed a broad genetic background and multiple signaling pathways leading to tumor development. Along with this, the diagnostic and therapeutic options were also expanded. In this review, we focus on the current knowledge and recent advancements in the diagnosis and treatment of PCCs/PGLs with respect to the underlying gene alterations while also discussing future perspectives in this field.
650    _2
$a lidé $7 D006801
650    12
$a feochromocytom $x diagnóza $x genetika $x terapie $7 D010673
650    12
$a paragangliom $x diagnóza $x genetika $x terapie $7 D010235
650    _2
$a karcinogeneze $7 D063646
650    _2
$a nádorová transformace buněk $7 D002471
650    12
$a nádory nadledvin $x diagnóza $x genetika $x terapie $7 D000310
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Foukal, Jakub $u Department of Radiology and Nuclear Medicine, University Hospital Brno, Faculty of Medicine, Masaryk University, Brno, Czech Republic $1 https://orcid.org/000000034321401X
700    1_
$a Sochorová, Dana $u Department of Surgery, University Hospital Brno, Faculty of Medicine, Masaryk University, Brno, Czech Republic $1 https://orcid.org/0000000319252892
700    1_
$a Tuček, Štěpán $u Department of Hematology, Oncology and Internal Medicine, University Hospital Brno, Faculty of Medicine, Masaryk University, Brno, Czech Republic $1 https://orcid.org/0000000245361155
700    1_
$a Starý, Karel $u Department of Gastroenterology and Internal Medicine, University Hospital Brno, Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Kala, Zdeněk $u Department of Surgery, University Hospital Brno, Faculty of Medicine, Masaryk University, Brno, Czech Republic $1 https://orcid.org/000000034187388X
700    1_
$a Mayer, Jiří $u Department of Hematology, Oncology and Internal Medicine, University Hospital Brno, Faculty of Medicine, Masaryk University, Brno, Czech Republic $1 https://orcid.org/0000000305679887
700    1_
$a Němeček, Radim $u Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Faculty of Medicine, Masaryk University, Brno, Czech Republic $1 https://orcid.org/0000000168250960
700    1_
$a Trna, Jan $u Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Faculty of Medicine, Masaryk University, Brno, Czech Republic $u Department of Gastroenterology and Digestive Endoscopy, Masaryk Memorial Cancer Institute, Brno, Czech Republic $1 https://orcid.org/0000000331389736
700    1_
$a Kunovský, Lumír $u Department of Surgery, University Hospital Brno, Faculty of Medicine, Masaryk University, Brno, Czech Republic $u Department of Gastroenterology and Digestive Endoscopy, Masaryk Memorial Cancer Institute, Brno, Czech Republic $u 2nd Department of Internal Medicine - Gastroenterology and Geriatrics, University Hospital Olomouc, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic $1 https://orcid.org/0000000329858759
773    0_
$w MED00181704 $t Cancer medicine $x 2045-7634 $g Roč. 12, č. 13 (2023), s. 13942-13957
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37145019 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20231013 $b ABA008
991    __
$a 20231026105352 $b ABA008
999    __
$a ok $b bmc $g 2000493 $s 1203366
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 12 $c 13 $d 13942-13957 $e 20230505 $i 2045-7634 $m Cancer medicine $n Cancer Med $x MED00181704
LZP    __
$a Pubmed-20231013

Najít záznam

Citační ukazatele

Možnosti archivace